Skip to content

Drug interactions

Armodafinil + Imatinib

Severity: Minor

Armodafinil and Imatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Armodafinil is a weak inducer of CYP3A4 and could modestly lower imatinib exposure. The effect is expected to be small, and a meaningful loss of imatinib efficacy has not been well documented.

What this interaction means in plain words

Armodafinil and Imatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Armodafinil belongs to Central Nervous System; Imatinib belongs to Oncology.

Evidence level: Low

Why it happens

Weak induction of CYP3A4 by armodafinil may increase imatinib metabolism.

What to do

No routine dose change is needed. Watch for reduced response to imatinib if armodafinil is started or stopped in a patient on stable therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Imatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Armodafinil with Imatinib?

MediHelp rates the interaction as minor. Armodafinil and Imatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Armodafinil is a weak inducer of CYP3A4 and could modestly lower imatinib exposure. The effect is expected to be small, and a meaningful loss of imatinib efficacy has not been well documented.

How serious is the interaction between Armodafinil and Imatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Watch for reduced response to imatinib if armodafinil is started or stopped in a patient on stable therapy.

What other medicines interact with Armodafinil?

MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in